Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis
Immunologic Research · 2024
DOI: 10.1007/s12026-024-09486-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunologic Research, 2024. Verfasst von Ziliang Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, No.666 Shengli Road, Nantong, 226000, Jiang…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Histone Demethylases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Nantong First People's Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund, Nantong Youth Medical Expert Project.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction. Lysine-specific demethylase 1 (LSD1), an enzyme involved in transcriptional regulation, has an unclear role in synovial inflammation, fibroblast-like synoviocytes migration, and invasion during RA pathogenesis. In this study, we observed increased LSD1 expression in RA synovial tissues and in TNF-α-stimulated MH7A cells. SP2509, an LSD1 antagonist, directly reduced LSD1 expression and reversed the elevated levels of proteins associated with inflammation, apoptosis, proliferation, and autophagy induced by TNF-α. Furthermore, SP2509 inhibited the migratory capacity of MH7A cells, which was enhanced by TNF-α. In CIA models, SP2509 treatment ameliorated RA development, reducing the expression of pro-inflammatory cytokines and alleviating joint pathological symptoms. These findings underscore the significance of LSD1 in RA and propose the therapeutic potential of SP2509.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, No.666 Shengli Road, Nantong, 226000, Jiangsu, China.
- Department of Operating Room, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Nantong, 226000, Jiangsu, China.
- Department of Orthopaedics, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Nantong, 226000, Jiangsu, China.
- Department of Orthopaedics, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, No.666 Shengli Road, Nantong, 226000, Jiangsu, China. liuweidr@yeah.net.
- Department of Orthopaedics, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, No.666 Shengli Road, Nantong, 226000, Jiangsu, China. zhanghaipingx@163.com.
Förderung
- Nantong First People's Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund
- Nantong Youth Medical Expert Project
Zitieren
APA
Yu, Z., Li, P., Gao, D., Hu, Y., Xia, F., Liu, L., Liu, J., Liu, W., & Zhang, H. (2024). Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis. Immunologic Research. https://doi.org/10.1007/s12026-024-09486-5
Vancouver
Yu Z, Li P, Gao D, Hu Y, Xia F, Liu L, et al. Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis. Immunologic Research. 2024. doi:10.1007/s12026-024-09486-5
BibTeX
@article{Yu2024,
author = {Yu, Ziliang and Li, Peipei and Gao, Dagong and Hu, Yalong and Xia, Fei and Liu, Lei and Liu, Jian and Liu, Wei and Zhang, Haiping},
title = {Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis},
journal = {Immunologic Research},
year = {2024},
doi = {10.1007/s12026-024-09486-5}
}
EUVIMED